Neuralink Stock
HealthTechLooking to sell Neuralink stock or options?
Eligible for:
Charitable Exchange Fund
Neuralink is developing an implantable brain-machine interface aimed at assisting individuals with paralysis. This interface is designed to treat and diagnose neurological disorders in humans and potentially enhance cognitive abilities. In the near term, it allows doctors to address severe brain conditions.
Investors Include:
Blake Byers, Frederick Ehrsam, GigaFund, Sam Altman, Calm Ventures, Ken Howery, EXOR Seeds, Valor Equity Partners, G42, Alphabet, Time BioVentures, Beyond Capital, Raison, MicroVentures, Founders Fund, Oak Grove Ventures, Capital Advantage Ventures, Lightspeed Venture Partners, Shake and Bake, Vy Capital, Robert Nelson, Type One Ventures, HOF Capital, Humla Ventures, Redefine Ventures.